StockData
Akari Therapeutics Plc logo

Akari Therapeutics Plc (AKTX) stock

AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$5.70−0.81 (-12.44%)

Close on Nov 17, 2026Market cap $11.10MP/E –Yield –

Akari Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Akari Therapeutics's total assets was $38.62M at Jun 30, 2026. For fiscal 2025 it was $47.89M, down 5.3% from the year before. Over ten years it grew -3.7% a year on average. The highest annual figure on record is $69.89M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$47.89M-5.3%
FY2024Dec 31, 2024$50.56M+1061.0%
FY2023Dec 31, 2023$4.36M-68.5%
FY2022Dec 31, 2022$13.83M+18.7%
FY2021Dec 31, 2021$11.65M-20.2%
FY2020Dec 31, 2020$14.60M+125.4%
FY2019Dec 31, 2019$6.48M-19.3%
FY2018Dec 31, 2018$8.03M-72.4%
FY2017Dec 31, 2017$29.05M-36.7%
FY2016Dec 31, 2016$45.87M-34.4%
FY2015Dec 31, 2015$69.89M+1958.9%
FY2014Dec 31, 2014$3.39M-56.7%
FY2013Dec 31, 2013$7.83M+599.3%
FY2012Dec 31, 2012$1.12M+4048.1%
FY2011Dec 31, 2011$27.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$38.62M-24.1%
Q1 FY2026Mar 31, 2026$33.89M-33.5%
Q4 FY2025Dec 31, 2025$47.89M-5.3%
Q3 FY2025Sep 30, 2025$45.38M+1559.7%
Q2 FY2025Jun 30, 2025$50.91M+903.0%
Q1 FY2025Mar 31, 2025$50.96M+1738.3%
Q4 FY2024Dec 31, 2024$50.56M+1061.0%
Q3 FY2024Sep 30, 2024$2.73M-65.9%
Q2 FY2024Jun 30, 2024$5.08M-63.3%
Q1 FY2024Mar 31, 2024$2.77M-75.6%
Q4 FY2023Dec 31, 2023$4.36M-62.6%
Q2 FY2023Jun 30, 2023$8.01M+65.9%
Q4 FY2022Dec 31, 2022$13.83M-5.3%
Q2 FY2022Jun 30, 2022$11.37M-17.0%
Q4 FY2021Dec 31, 2021$11.65M-19.4%
Q2 FY2021Jun 30, 2021$4.83M-50.1%
Q4 FY2020Dec 31, 2020$14.60M+125.4%
Q3 FY2020Sep 30, 2020$13.69M+33.4%
Q2 FY2020Jun 30, 2020$14.45M+213.3%
Q1 FY2020Mar 31, 2020$9.68M+17.6%
Q4 FY2019Dec 31, 2019$6.48M-19.3%
Q3 FY2019Sep 30, 2019$10.27M-40.0%
Q2 FY2019Jun 30, 2019$4.61M-84.1%
Q1 FY2019Mar 31, 2019$8.23M-74.3%
Q4 FY2018Dec 31, 2018$8.03M-82.5%
Q2 FY2018Jun 30, 2018$17.12M-70.3%
Q4 FY2017Dec 31, 2017$29.05M-53.9%
Q2 FY2017Jun 30, 2017$32.05M-54.1%
Q4 FY2016Dec 31, 2016$45.87M-42.1%
Q2 FY2016Jun 30, 2016$57.63M+1847.1%
Q1 FY2016Mar 31, 2016$62.96M+1358.4%
Q4 FY2015Dec 31, 2015$69.89M+1958.9%
Q3 FY2015Sep 30, 2015$79.17M–
Q2 FY2015Jun 30, 2015$2.96M–
Q1 FY2015Mar 31, 2015$4.32M–
Q4 FY2014Dec 31, 2014$3.39M–

More Akari Therapeutics figures

See a number that looks wrong?